Vesicular stomatitis Indiana virus
"Vesicular stomatitis Indiana virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of VESICULOVIRUS causing a disease symptomatically similar to FOOT-AND-MOUTH DISEASE in cattle, horses, and pigs. It may be transmitted to other species including humans, where it causes influenza-like symptoms.
| Descriptor ID |
D014721
|
| MeSH Number(s) |
B04.820.455.750.900.900
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vesicular stomatitis Indiana virus".
Below are MeSH descriptors whose meaning is more specific than "Vesicular stomatitis Indiana virus".
This graph shows the total number of publications written about "Vesicular stomatitis Indiana virus" by people in this website by year, and whether "Vesicular stomatitis Indiana virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vesicular stomatitis Indiana virus" by people in Profiles.
-
Bueno MT, Reyes D, Valdes L, Saheba A, Urias E, Mendoza C, Fregoso OI, Llano M. Poly(ADP-ribose) polymerase 1 promotes transcriptional repression of integrated retroviruses. J Virol. 2013 Mar; 87(5):2496-507.
-
Yuan H, Fu F, Zhuo J, Wang W, Nishitani J, An DS, Chen IS, Liu X. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis. Oncogene. 2005 Jul 28; 24(32):5069-78.
-
Hoshino H, Nakamura T, Tanaka Y, Miyoshi I, Yanagihara R. Functional conservation of the neutralizing domains on the external envelope glycoprotein of cosmopolitan and melanesian strains of human T cell leukemia/lymphoma virus type I. J Infect Dis. 1993 Dec; 168(6):1368-73.
-
Zielinska-Jenczylik J, Inglot AD, Inglot O, Popik W. Transforming growth factor-beta inhibits the antiviral action of interferons in human embryonic fibroblasts. J Interferon Res. 1991 Apr; 11(2):87-9.
-
Piasecki E, Popik W, Inglot AD, Konieczny M, Charytonowicz D. New derivatives of blue dextran binding and stabilizing human or mouse interferons. Arch Immunol Ther Exp (Warsz). 1984; 32(2):231-8.
-
Banerjee DK, Baksi K, Gottesman MM. Genetic evidence that action of cAMP-dependent protein kinase is not an obligatory step for antiviral and antiproliferative effects of human interferon in Chinese hamster ovary cells. Virology. 1983 Aug; 129(1):230-8.
-
Maheshwari RK, Banerjee DK, Waechter CJ, Olden K, Friedman RM. Interferon treatment inhibits glycosylation of a viral protein. Nature. 1980 Oct 02; 287(5781):454-6.